With regulatory standards tightening, cost-cutting pressures increasing, and demand for scalable, efficient mRNA production expanding, it would be a shame to miss out on concrete methods to address these difficulties.
Discover the key sessions geared to address your greatest challenges:
- MHRA fireside chat: Navigating regulatory expectations for mRNA manufacturing
Learn from the MHRA about evolving CMC expectations, submission criteria, and initiatives for streamlining approval routes for mRNA platforms.
- Continuous processing: Optimizing efficiency & scalability in mRNA production
Learn how CEPI and UO Sheffield move purification and production from batch to continuous processes to promote scalability, reproducibility, and cost savings.
- Synthetic DNA workshop: Revolutionizing mRNA vaccine & therapeutic development
With Genevation, explore the most recent advancements in synthetic DNA as a template for mRNA creation, including reducing timelines, improving stability, and ensuring higher yield and purity.
- Room temperature formulations: Advancing stability & global distribution
Learn about Altamira and Divincell's cutting-edge formulation techniques for thermostable mRNA products, which reduce cold chain dependencies and increase global accessibility.
Do not pass up the opportunity to join a room full of CMC, purification, regulatory, stabilization, process, and IVT innovators and decision-makers.
Join more than 100 experts in Upstream & Downstream Process Development, Analytical Development, CMC, Manufacturing, and Drug Product at the 3rd mRNA Process Development & Manufacturing Summit Europe to drive innovation, establish key frameworks, and forge partnerships to overcome process, scale, and regulatory challenges, ensuring safe and effective mRNA drugs from research to clinic and beyond.
Interactive regulatory panel discussion
- On Day One, join regulatory experts to discuss the changing approval landscape for mRNA therapies and vaccines.
- Gain unique access to the most recent rules and end-to-end tactics for streamlining your regulatory pathway, resulting in faster and easier product approval.
Pioneering advances in biotech
Learn from Ceva, Altamira, and Divincells about next-gen formulations, stabilization techniques, and advanced purification processes for efficient and cost-effective production, reducing the time from lab to market.
About Hanson Wade Group - 3rd mRNA Process Development & Manufacturing Europe
The mRNA market is projected to reach $63.28 billion by 2025, indicating an all-time high global demand for mRNA vaccines and therapeutics.
Now more than ever, robust process development and manufacturing are essential to ensure patients have access to life-saving treatments. While the industry is making strides in continuous processing, advanced analytics, improved scalability, and innovative formulations, significant challenges remain, including controlling impurities, long manufacturing timelines, and navigating complex regulatory pathways for timely approvals.
The 3rd mRNA Process Development & Manufacturing Summit 2025 returns as Europe’s premier industry-focused forum, dedicated to optimizing process development for mRNA therapeutics and vaccines. This event will address end-to-end process optimization and regulatory compliance to streamline approvals while also advancing scalable and cost-efficient manufacturing solutions to support drug developers in delivering safer and more effective mRNA drugs to patients faster.
Bringing together leading experts from CEPI, Merck, CureVac, BioNTech, Altamira, Genevation, and more, this summit will showcase cutting-edge advancements in end-to-end process development and manufacturing to support the production of high-quality, cost-effective mRNA therapeutics at scale.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.